| 21st Feb 2025 7:00 am |
RNS |
Directorate Change |
| 21st Feb 2025 7:00 am |
RNS |
Director/PDMR Shareholding |
| 21st Feb 2025 7:00 am |
RNS |
Director/PDMR Shareholding |
| 21st Feb 2025 7:00 am |
RNS |
Director/PDMR Shareholding |
| 21st Feb 2025 7:00 am |
RNS |
Director/PDMR Shareholding |
| 21st Feb 2025 7:00 am |
RNS |
Director/PDMR Shareholding |
| 21st Feb 2025 7:00 am |
RNS |
Director/PDMR Shareholding |
| 20th Feb 2025 7:00 am |
RNS |
Nucala COPD submission accepted in China |
| 17th Feb 2025 7:00 am |
RNS |
GSK 5-in-1 meningitis vaccine approved by US FDA |
| 13th Feb 2025 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 11th Feb 2025 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 5th Feb 2025 7:00 am |
RNS |
Final Results |
| 3rd Feb 2025 4:48 pm |
RNS |
Total Voting Rights |
| 28th Jan 2025 7:05 am |
RNS |
Depemokimab dual filing in China and Japan |
| 28th Jan 2025 7:00 am |
RNS |
EMA accepts two submissions for depemokimab |
| 27th Jan 2025 7:05 am |
RNS |
EMA accept review Shingrix syringe presentation |
| 20th Jan 2025 7:00 am |
RNS |
Jemperli expanded approval in the EU |
| 16th Jan 2025 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 15th Jan 2025 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 14th Jan 2025 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 13th Jan 2025 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 13th Jan 2025 7:00 am |
RNS |
GSK enters agreement to acquire IDRx, Inc. |
| 10th Jan 2025 7:00 am |
RNS |
Shingrix fully liquid accepted for US FDA review |
| 7th Jan 2025 7:00 am |
RNS |
GSK ADC gets FDA breakthrough therapy designation |
| 3rd Jan 2025 7:00 am |
RNS |
GSK’s Nucala approved in China for use in CRSwNP |
| 2nd Jan 2025 3:00 pm |
RNS |
Total Voting Rights |
| 23rd Dec 2024 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 20th Dec 2024 9:00 am |
RNS |
Block Listing Application |
| 20th Dec 2024 7:00 am |
RNS |
Headline results from phase III FIRST trial |
| 16th Dec 2024 7:11 am |
RNS |
Jemperli receives US FDA breakthrough designation |
| 16th Dec 2024 7:05 am |
RNS |
EMA grants PRIME Designation for GSK’227 |
| 16th Dec 2024 7:00 am |
RNS |
Jemperli receives positive CHMP opinion |
| 12th Dec 2024 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 9th Dec 2024 6:29 pm |
RNS |
Overall survival data presented for Blenrep |
| 9th Dec 2024 7:05 am |
RNS |
Blenrep combination China filing acceptance |
| 9th Dec 2024 7:00 am |
RNS |
Nucala COPD submission accepted by US FDA |
| 5th Dec 2024 7:00 am |
RNS |
Zhifei China collaboration revised and extended |
| 2nd Dec 2024 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 2nd Dec 2024 3:00 pm |
RNS |
Total Voting Rights |
| 27th Nov 2024 7:00 am |
RNS |
GSK liquid meningitis vaccine authorised in EU |
